8-K current report · filed Sep 30, 2026

CARLSMED, INC. (CARL) 8-K Current Report: September 30, 2026

Item 5.02Item 7.01Item EX-99.1CARL overview

Short answer

CARLSMED, INC. (CARL) filed an 8-K current report with the SEC on September 30, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). CFO Leo Greenstein departed September 25, 2026 without accounting or internal-control disagreements.

CARLSMED, INC. 8-K event analysis

AI summary of each reported item and its exhibits

Item 5.02 · Departure/Election of Directors or Officers

  • CFO Leo Greenstein departed September 25, 2026 without accounting or internal-control disagreements
  • Separation package includes $500,000 cash, pro-rated 2026 incentive, COBRA for 12 months, and accelerated equity vesting
  • Richard Heppenstall appointed CFO September 28, 2026, bringing prior medical-device finance leadership at ZimVie, Breg, and Orthofix
  • New CFO receives $500,000 base salary, 60% target incentive, and $2,800,000 in inducement equity awards
  • Transition costs include up to $150,000 relocation reimbursement and advisory payments of $60,000 to Greenstein through December 31, 2026

Item 7.01 · Regulation FD Disclosure

  • Heppenstall appointed Chief Financial Officer effective September 28, 2026
  • Leadership change potentially relevant to financial reporting, capital strategy, and investor communications
  • Press release details available in Exhibit 99.1

Item EX-99.1 · Exhibit EX-99.1

  • Richard Heppenstall appointed CFO effective immediately, replacing Leo Greenstein after three years
  • Heppenstall brings nearly 30 years across healthcare, life sciences, and technology, including CFO experience at ZimVie and Breg
  • FY2026 revenue guidance reaffirmed at $74–$78 million, implying 50% growth at the midpoint
  • October 1 CMS reimbursement effective for aprevo Lumbar, supporting commercialization and adoption prospects
  • Upcoming aprevo Lumbar Bi-lateral and corra cervical launches increase execution demands under new financial leadership

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other CARLSMED, INC. 8-K filings

Get the next CARL 8-K as it lands

Follow CARL for push alerts, or ask the research agent what this filing means.